4503.T ASTELLAS PHARMA | JP3942400007
Financials
Trends
Details
| Breakdown | 31.03.2028 | 31.03.2027 | Change % |
|---|---|---|---|
| Total Revenue | 2.074.785.959.580 | 2.260.914.643.000 | 8.23% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 183,28 | 192,18 | 4.63% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 12 | 12 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |